Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuchu Li

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|February 14, 2022
Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients CohortShihan Zhang, Ke Xu, Chuchu Li, et al.
Frontiers in Public Health|June 14, 2024
The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, ChinaJinjin Chu, Qigang Dai, Chen Dong, et al.
Microbiology Spectrum|October 27, 2025
Transiently produced IgGs enable universal SARS-CoV-2 diagnosis and differentiation recent from past infectionsChuchu Li, Jingzhi Li, Chen Dong, et al.
Frontiers in Microbiology|June 14, 2019
Novel <i>Yersinia enterocolitica</i> Prophages and a Comparative Analysis of Genomic DiversityJunrong Liang, Zengqiang Kou, Shuai Qin, et al.
Vaccines|November 26, 2024
Neutralizing Antibody-Mediated Protection from Prior Delta Variant Infection Against Omicron BA.5 Sub-Lineage Reinfection One Year Later: A Prospective Cohort StudyShihan Zhang, Yin Wang, Guo Xu, et al.
Toxins|May 30, 2019
Fengycin Produced by <i>Bacillus amyloliquefaciens</i> FZB42 Inhibits <i>Fusarium graminearum</i> Growth and Mycotoxins BiosynthesisAlvina Hanif, Feng Zhang, Pingping Li, et al.
Frontiers in Immunology|February 10, 2023
Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infectionAidibai Simayi, Chuchu Li, Cong Chen, et al.
Journal of Medical Virology|January 9, 2025
Dynamic Changes and Trends of SARS-CoV-2 Antibodies Induced by Infection and Vaccination Across Multiple Time PointsShihan Zhang, Xiaoxiao Kong, Qian Zhen, et al.
Microbiology Spectrum|July 11, 2023
Unveiling a New Perspective on Distinguishing Omicron Breakthrough Cases and Postimmune COVID-19-Naive Individuals: Insights from Antibody ProfilesShihan Zhang, Chen Dong, Qian Zhen, et al.
One Health (Amsterdam, Netherlands)|July 30, 2025
Cross-neutralization of human sera with diverse SARS-CoV-2 omicron exposure histories, 2022-2024: Evidence of immune heterogeneityShihan Zhang, Qian Zhen, Liling Chen, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|February 14, 2022
Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients CohortShihan Zhang, Ke Xu, Chuchu Li, et al.
Frontiers in Public Health|June 14, 2024
The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, ChinaJinjin Chu, Qigang Dai, Chen Dong, et al.
Microbiology Spectrum|October 27, 2025
Transiently produced IgGs enable universal SARS-CoV-2 diagnosis and differentiation recent from past infectionsChuchu Li, Jingzhi Li, Chen Dong, et al.
Frontiers in Microbiology|June 14, 2019
Novel <i>Yersinia enterocolitica</i> Prophages and a Comparative Analysis of Genomic DiversityJunrong Liang, Zengqiang Kou, Shuai Qin, et al.
Vaccines|November 26, 2024
Neutralizing Antibody-Mediated Protection from Prior Delta Variant Infection Against Omicron BA.5 Sub-Lineage Reinfection One Year Later: A Prospective Cohort StudyShihan Zhang, Yin Wang, Guo Xu, et al.
Toxins|May 30, 2019
Fengycin Produced by <i>Bacillus amyloliquefaciens</i> FZB42 Inhibits <i>Fusarium graminearum</i> Growth and Mycotoxins BiosynthesisAlvina Hanif, Feng Zhang, Pingping Li, et al.
Frontiers in Immunology|February 10, 2023
Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infectionAidibai Simayi, Chuchu Li, Cong Chen, et al.
Journal of Medical Virology|January 9, 2025
Dynamic Changes and Trends of SARS-CoV-2 Antibodies Induced by Infection and Vaccination Across Multiple Time PointsShihan Zhang, Xiaoxiao Kong, Qian Zhen, et al.
Microbiology Spectrum|July 11, 2023
Unveiling a New Perspective on Distinguishing Omicron Breakthrough Cases and Postimmune COVID-19-Naive Individuals: Insights from Antibody ProfilesShihan Zhang, Chen Dong, Qian Zhen, et al.
One Health (Amsterdam, Netherlands)|July 30, 2025
Cross-neutralization of human sera with diverse SARS-CoV-2 omicron exposure histories, 2022-2024: Evidence of immune heterogeneityShihan Zhang, Qian Zhen, Liling Chen, et al.
Pageof 9